Table 1. Effects of chitosan oligosaccharide supplementation on the amniotic fluid antioxidant status of sowsa.
Items | Treatmentsb |
P-value | |
---|---|---|---|
CON | COS | ||
SODc (U/mL) | 60.26 ± 4.80 | 69.07 ± 6.46* | 0.023 |
CATd (U/mL) | 3.61 ± 0.60 | 5.22 ± 0.53** | <0.001 |
ASAe (U/L) | 89.29 ± 1.86 | 104.68 ± 6.44** | 0.005 |
AHRf (U/mL) | 398.23 ± 12.72 | 426.41 ± 14.15* | 0.011 |
T-AOCg (U/mL) | 2.64 ± 0.16 | 3.26 ± 0.59* | 0.048 |
GSHh (mg/mL) | 0.29 ± 0.06 | 0.31 ± 0.06 | 0.598 |
MDAi (nm/mL) | 4.90 ± 0.71 | 4.56 ± 0.56 | 0.386 |
*P < 0.05 versus the CON group. **P < 0.01 versus the CON group.
aValues are means of six replications per treatment.
bCON: A corn–soybean basal diet; COS: Chitosan oligosaccharide (the basal diet supplemented with 100 mg/kg chitosan oligosaccharide).
cSOD: Superoxyde dismutase.
dCAT: Catalase.
eASA: Anti-superoxide anion.
fAHR: Anti-hydroxyl radical.
gT-AOC: Total antioxidant capacity.
hGSH: Glutathione.
iMDA: Malondialdehyde.